People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Syntis Bio, Inc. | — | Biotechnology | Series B | $46.7M | $118.0M | 2022 |
TEYMOUR GIOVANNI BOUTROS-GHALI at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside TEYMOUR GIOVANNI BOUTROS-GHALI on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Carlo Giovanni Traverso | 1 | 6 |
| Teymour Boutros-Ghali | 1 | 5 |
| Michael Nannizzi | 1 | 3 |
| Martin Madaus | 1 | 3 |
| ROBERT GIOVANNI LANGER | 1 | 2 |
| Rahul Dhanda | 1 | 2 |
| MARTIN GIOVANNI MADAUS | 1 | 1 |
| RAHUL K. DHANDA | 1 | 1 |
| Chenny Zhang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.